ÂÜÀòÂÒÂ×

Amin Osmani has a diverse work experience in various companies. Amin started their career in 2011 as a Business Development Manager at MEDISCA, where they worked until 2015. After that, they joined The CLINICAL TRIAL Company Ltd as a Sales Manager for North America, working from 2015 to 2017. In 2016, they became a Business Development Consultant, a role they held until 2020. In 2018, they joined ImmunXperts as a Business Development Manager, where they worked until November 2020. Currently, Amin is the CEO of Cedience, a position they have held since January 2019.

Amin Osmani's education history begins in 2002 when they enrolled in McGill University and pursued a Bachelor's Degree in Biology, completing it in 2006. Following this, from 2007 to 2008, Amin attended Concordia University where they obtained a Graduate Diploma in Biotechnology & Genomics. Continuing their academic journey, Amin pursued a Master's Degree in Biology at Concordia University from 2008 to 2013.

In 2014, Amin took graduate courses at McGill University, focusing on Business Administration and Management in a general field. Additionally, they obtained various certifications to augment their skills and knowledge. These include a Strategic Management Training certification from Strategic Coach in October 2014, as well as certifications in fields such as healthcare innovation and entrepreneurship, clinical trial design and interpretation, and Python programming.

Overall, Amin Osmani's educational background showcases a diverse range of studies in both the biological and business fields, with a focus on biology during their undergraduate and graduate studies.